[Ip-health] MSF response to new UNAIDS treatment figures

Joanna Keenan joanna.l.keenan at gmail.com
Fri Jun 3 08:56:05 PDT 2011


With the UN High Level Meeting on AIDS taking place in New York next week,
UNAIDS has today released the new figure of 6.6 million people on ARV
treatment for HIV in developing countries, up from 6 million last year and a
near 22-fold increase from 2001 (
http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2011/june/20110603praids30/).


Medecins Sans Frontieres has issued the below response from Campaign for
Access to Essential Medicines Executive Director Dr Tido von Schoen-Angerer:

Response to new number of people on treatment in developing countries:

“It is encouraging to see that treatment is expanding in poor countries –
but the pace has to be picked up if the world wants to get ahead of the wave
of new infections and make use of the latest science that HIV treatment is
also HIV prevention. World leaders meeting at the UN AIDS summit next week
have the best opportunity to translate the latest science [on HIV treatment
as HIV prevention] into policies that could break the back of the HIV
epidemic. This is not the time for a mediocre response that leaves the job
only half done.”

Dr. Tido von Schoen-Angerer, Executive Director, Médecins Sans Frontières
Campaign for Access to Essential Medicines

And the Lancet has published UNAIDS projections that 12 million new
infections and 7 million new deaths could be averted by 2020 if universal
access to treatment is achieved (
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60702-2/fulltext);
Dr von Schoen-Angerer's response is also included below:

Response to possible infections and deaths averted if universal access is
achieved:

“These projections show the impact that expanding treatment could have if
world leaders stand up at the AIDS summit next week and show they are
willing to make the most of the latest evidence that HIV treatment can also
prevent transmission of the virus. The research shows that the question is
not only how many people you treat, but how soon. We want to see ambitious
answers from world leaders at next week's AIDS summit, otherwise, we will
have squandered the best chance to get ahead of the wave of new infections"

Dr. Tido von Schoen-Angerer, Executive Director, Médecins Sans Frontières
Campaign for Access to Essential Medicines



More information about the Ip-health mailing list